Related Experiment Videos

Mitral valve prolapse as a risk factor for TIA. A study with echocardiography and dynamic ECG

European Neurology
|January 1, 1983
PubMed

Insights

Mitral valve prolapse (MVP) is a risk factor for focal cerebral ischemia in young patients, particularly those without traditional vascular risks. Further cardiac evaluation is crucial for identifying these cases.

Area of Science:

  • Neurology
  • Cardiology
  • Vascular Medicine

Background:

  • Reversible focal cerebral ischemia can occur without apparent cardiopathy or atherosclerosis.
  • Vascular risk factors like hypertension and hyperlipemia are common in affected patients.
  • A subset of patients with cerebral ischemia lacks identifiable clinical, hematochemical, or cardiological abnormalities.

Purpose of the Study:

  • To investigate the role of cardiac abnormalities, specifically mitral valve prolapse (MVP), in patients with unexplained focal cerebral ischemia.
  • To determine if MVP is associated with cerebral ischemia in younger individuals or those without conventional vascular risk factors.

Main Methods:

  • Analysis of 120 patients with reversible focal cerebral ischemia.
  • Clinical, hematochemical, and cardiological examinations.
  • Echocardiography and dynamic electrocardiography (Holter monitoring) in specific patient subgroups.
  • Assessment of vascular risk factors (hypertension, hyperlipemia).

Main Results:

  • 77% of patients had vascular risk factors; 23% had no initial abnormalities.
  • Cardiac evaluations identified 6 cases of mitral valve prolapse (MVP), 2 with frequent premature ventricular beats, and 1 with atrial arrhythmia.
  • All 6 MVP cases were found in patients without vascular risk factors.
  • In patients under 45 years old, MVP occurred in 21.5%.

Conclusions:

  • Mitral valve prolapse (MVP) is confirmed as a significant risk factor for focal cerebral ischemia, especially in younger patients.
  • The study highlights the importance of cardiac evaluation, including echocardiography, for patients presenting with unexplained cerebral ischemia, even in the absence of traditional risk factors.
  • MVP should be considered in the differential diagnosis of ischemic stroke in young adults without typical cardiovascular risk profiles.

Related Concept Videos